SRS Capital Advisors »

Astria Therapeutics shares owned by SRS Capital Advisors

Quarter-by-quarter ownership of Astria Therapeutics (ATXS) shares owned by SRS Capital Advisors from 13F filings

Historical chart of SRS Capital Advisors investment in Astria Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Astria Therapeutics held by SRS Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Astria Therapeutics by SRS Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $145 20 7.25
2024-12-31 $581 65 8.95

More positions owned by SRS Capital Advisors

Vanguard Index Fds Growth Etf (VOO)
Ishares Tr Ishs 1-5yr Invs (OEF)
First Tr Exchange-traded Wtr Etf (FDL)
American Centy Etf Tr Us Large Cap Vlu (KORP)
Dimensional Etf Trust Intl Core Equity (DFAI)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Schwab Strategic Tr Us Tips Etf (SCHB)
Microsoft Corporation (MSFT)
First Tr Exchng Traded Fd Vi Smith Opport Fxd (FIXD)
First Tr Exchange Traded Risng Divd Achiv (FXN)
NVIDIA Corporation (NVDA)
First Tr Exch Traded Fd Iii Pfd Secs Inc Etf (FPE)
Spdr S&p 500 Etf Tr Tr Unit
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)

View all positions for SRS Capital Advisors

Top funds holding Astria Therapeutics

Perceptive Advisors
FMR
Vestal Point Capital
Fcpm Iii Services B.v.
Fairmount Funds Management
BlackRock
Millennium Management
TCG Crossover Management
Vanguard Group
VR Adviser
Jpmorgan Chase & Co
Vivo Capital
Rosalind Advisors
Driehaus Capital Management
Nantahala Capital Management

View all funds holding Astria Therapeutics